Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Darlinghurst
Clinical trial register · Australia

Clinical Trials in Darlinghurst, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 25 Brisbane 22 Adelaide 22 Box Hill 16 Westmead 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca29 Novartis Pharmaceuticals15 Eli Lilly and Company10 Gilead Sciences10 AbbVie9 Clear sponsor filter
Site location
Melbourne25 Brisbane22 Adelaide22 Box Hill16 Westmead11
All 95 locations
Target enrolment
to

Trials with a site in Darlinghurst

10 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Eli Lilly and Company
Phase 3
800
Ballarat Central, Brisbane, Darlinghurst, Hobart, Melbourne, Newcastle, North Ryde, Shepparton
2025-12-22
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
420
Darlinghurst, Nedlands
2024-07-01
Recruiting
Eli Lilly and Company
Phase 3
595
Darlinghurst, Melbourne, Mitcham, Wooloongabba
2023-02-27
Recruiting
Eli Lilly and Company
Phase 1
677
Darlinghurst, Hunter Region, NSW, St Leonards, Sydney
2023-01-12
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ballarat Central, Box Hill, Clayton, Coffs Harbour, Darlinghurst, Geelong, Hobart, Launceston
2022-10-04
Active, closed
Eli Lilly and Company
Phase 3
925
Camperdown, Coffs Harbour, Darlinghurst, Liverpool, Macquarie University, South Brisbane, Southport, Woolloongabba
2022-04-14
Active, closed
Eli Lilly and Company
Phase 3
874
Darlinghurst, Woolloongabba, Kurralta Park, Box Hill, Melbourne
2021-10-04
Active, closed
Eli Lilly and Company
Phase 1
200
Darlinghurst
2020-10-01
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
Darlinghurst, Waratah, Adelaide, Nedlands
2019-12-10
Active, closed
Eli Lilly and Company
Phase 3
5,637
Camperdown, Darlinghurst, Lismore, Liverpool, Sydney, Waratah, Westmead, Wollongong
2017-07-12
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/darlinghurst

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Darlinghurst that also match the filters currently applied.

How many clinical trials are recruiting in Darlinghurst?

4 of the 10 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Darlinghurst), 10 studies
PhaseStudiesRecruitingShare
Phase 36260%
Phase 14240%

Most active sponsors

Lead sponsors with the most studies (Darlinghurst)
Lead sponsorStudiesRecruiting
Eli Lilly and Company104
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.